EAN 2023 | Incorporating patient-reported outcome measures into clinical research

Sean Apap Mangion, MD, UCL Queen Square Institute of Neurology, London, UK, explores the challenge of selecting the most relevant patient-reported outcome measures for assessing the impact of multiple sclerosis (MS). He discusses the ongoing efforts to identify valuable outcome measures for clinical trials relevant to the individual treatments being studied and the population in question. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.